EAM
EFG Asset Management Portfolio holdings
AUM
$773M
1-Year Est. Return
40.1%
1 Year Est. Return
+40.1%
AUM
$708M
AUM Growth
+$106M
(+18%)
Holding
191
Top Buys
| 1 | +$4.2M | |
| 2 | +$4.07M | |
| 3 | +$3.93M | |
| 4 |
Applovin
APP
|
+$3.87M |
| 5 |
BridgeBio Pharma
BBIO
|
+$3.12M |
Top Sells
| 1 | +$12.6M | |
| 2 | +$12.2M | |
| 3 | +$4.91M | |
| 4 |
Hamilton Lane
HLNE
|
+$3.86M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
+$3.53M |
Sector Composition
| 1 | Technology | 29.17% |
| 2 | Healthcare | 23.69% |
| 3 | Industrials | 13.65% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
Hamilton Lane
HLNE
$6.52B
| – | – |
-25,965
|
|
||
177
Immunovant
IMVT
$5.51B
| – | – |
-130,356
|
|
||
178
Lennar Class A
LEN
$30B
| – | – |
-13,195
|
|
||
179
Levi Strauss
LEVI
$8.39B
| – | – |
-173,426
|
|
||
180
MSCI
MSCI
$44.7B
| – | – |
-3,530
|
|
||
181
Onto Innovation
ONTO
$10B
| – | – |
-26,067
|
|
||
182
Parker-Hannifin
PH
$118B
| – | – |
-3,858
|
|
||
183
Impinj
PI
$5.46B
| – | – |
-18,961
|
|
||
184
Rocket Pharmaceuticals
RCKT
$429M
| – | – |
-110,961
|
|
||
185
Sprouts Farmers Market
SFM
$7.93B
| – | – |
-32,144
|
|
||
186
Spotify
SPOT
$105B
| – | – |
-4,884
|
|
||
187
Spyre Therapeutics
SYRE
$2.57B
| – | – |
-82,472
|
|
||
188
UnitedHealth
UNH
$307B
| – | – |
-2,849
|
|
||
189
Vera Therapeutics
VERA
$3.44B
| – | – |
-109,281
|
|
||
190
Weatherford International
WFRD
$6.22B
| – | – |
-42,117
|
|
||
191
Rubrik
RBRK
$13.8B
| – | – |
-42,252
|
|